Next, an analysis of the clinicopathological features of 110 GC patients showed that TYRO3 was significantly related to tumor size, T stage, pTNM stage, and lymph node metastasis (P < 0.05) (Table 1), suggesting that TYRO3 might play a key role in GC progression and metastasis. This evidence concerns the gene TYRO3 and gastric cancer.